Bio-Techne (TECH) Deferred Taxes (2009 - 2026)
Bio-Techne's (TECH) quarterly Deferred Taxes came in at $2.8 million in Q1 2026, up 152.55% year-on-year from $1.1 million in Q1 2025, and up 4047.22% quarter-over-quarter from -$72000.0 in Q4 2025.
Bio-Techne (TECH) Deferred Taxes (2009 - 2026) Analysis & Trends
Bio-Techne's Deferred Taxes history runs 18 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- On a quarterly basis, Deferred Taxes rose 152.55% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was -$24.2 million, a 14.59% increase from a year earlier, with the FY2025 full-year figure at -$51.1 million, down 29.56% from the prior year.
- Deferred Taxes rose to $2.8 million in Q1 2026 per TECH's latest filing, from -$72000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $5.3 million in Q3 2025 and bottomed at -$32.3 million in Q2 2025.
- The 5-year median for Deferred Taxes is -$5.4 million (2025), against an average of -$6.6 million.
- Across the five-year window, Deferred Taxes tumbled 2586.41% in 2023 and surged 198.78% in 2025, its largest moves.
- Year by year, Deferred Taxes stood at -$1.6 million in 2022, then slumped by 571.03% to -$10.7 million in 2023, then advanced by 24.68% to -$8.1 million in 2024, then soared by 99.11% to -$72000.0 in 2025, then soared by 4047.22% to $2.8 million in 2026.
- Per Business Quant, the three latest TECH Deferred Taxes figures stand at $2.8 million (Q1 2026), -$72000.0 (Q4 2025), and $5.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | 2.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.84 Mn |
| Dec 31, 2025 | -72,000.00 |
| Sep 30, 2025 | 5.28 Mn |
| Jun 30, 2025 | -32.28 Mn |
| Mar 31, 2025 | -5.41 Mn |
| Dec 31, 2024 | -8.08 Mn |
| Sep 30, 2024 | -5.34 Mn |
| Jun 30, 2024 | -9.55 Mn |
| Mar 31, 2024 | -7.58 Mn |
| Dec 31, 2023 | -10.72 Mn |
| Sep 30, 2023 | -11.59 Mn |
| Jun 30, 2023 | -6.92 Mn |
| Mar 31, 2023 | -16.29 Mn |
| Dec 31, 2022 | -1.60 Mn |
| Sep 30, 2022 | -4.77 Mn |
| Jun 30, 2022 | -1.07 Mn |
| Mar 31, 2022 | 655,000.00 |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 5.41 Mn |
| Jun 30, 2021 | -21.41 Mn |